Evogene Ltd. (EVGN)
NASDAQ: EVGN
· Real-Time Price · USD
1.11
0.03 (2.30%)
At close: Jun 02, 2025, 2:27 PM
2.30% (1D)
| Bid | 1.08 |
| Market Cap | 7.41M |
| Revenue (ttm) | 8.51M |
| Net Income (ttm) | -16.48M |
| EPS (ttm) | -2.51 |
| PE Ratio (ttm) | -0.44 |
| Forward PE | -0.78 |
| Analyst | Buy |
| Ask | 1.14 |
| Volume | 10,434 |
| Avg. Volume (20D) | 374,312 |
| Open | 1.11 |
| Previous Close | 1.08 |
| Day's Range | 1.07 - 1.12 |
| 52-Week Range | 0.95 - 7.60 |
| Beta | 1.29 |
About EVGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+30.93%
Evogene shares are trading higher after the compan...
Unlock content with
Pro Subscription
8 months ago
+19.92%
Evogene shares are trading higher after the company announced its subsidiary received a grant from the Israel Innovation Authority to advance its program to develop a technology for the delivery of Ag-biologicals to agriculture.
